Bethan McAvan

Bethan McAvan is an Analytical Development Senior Scientist at AstraZeneca, specializing in late-phase analytical development within the pharmaceutical industry. With over four years of experience, Bethan has a strong background in analytical method development, validation, and control strategy across various modalities, including oral solid dosage, peptides, and nanoparticles. They have demonstrated expertise in vibrational spectroscopy, project leadership, and regulatory submissions, while also mentoring scientists and optimizing analytical methods for compliance and efficiency. Bethan earned a Doctor of Philosophy (PhD) in Biochemistry from the University of Manchester and holds a 1st Class Degree with Honours in Medicinal Chemistry from the University of Leeds.